Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

116.12 +0.50 (+0.43%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Why Abbott Is Trading Lower Today
Abbott Laboratories (NYSE: ABT) is trading lower Tuesday morning after the company issued an updated outlook for 2021 below estimates. What Happened: Abbott announced... 
Via Benzinga
Abbott Stock Crumbles On Guidance Cut As Covid Testing Demand Slides
Abbott Laboratories cut its full-year outlook Tuesday, reflecting lower demand for Covid tests, and Abbott stock toppled. 
Via Investor's Business Daily
AbbVie (ABBV): An Undervalued Dividend Aristocrat
AbbVie Inc (ABBV) has an established eight-year track record of producing outstanding returns and superior dividend growth. Strong cash flow will enable ABBV to deleverage the balance sheet and support... 
Via Talk Markets
15 Blue-Chip Dividend Growth Stocks: Love The Businesses Hate The Stocks
I love blue-chip dividend growth stocks that consistently grow their businesses and their dividends year after year. 
Via Talk Markets
The Power and Precision of BioSig's PURE EP™ System in the Electrophysiology (EP) Market
Arrhythmia, a condition that causes the heart to beat with an irregular or abnormal rhythm, is the fourth leading disease in the United States. Untreated or undiagnosed,... 
Via Benzinga
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
Abbott (ABT) Q1 Earnings And Revenues Miss Estimates
Abbott came out with quarterly earnings of $1.32 per share, missing the Zacks Consensus Estimate of $1.33 per share. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
A Quartet Of Aristocrats
If we assembled a group of blue-chip stocks for income investors, it would likely resemble the Dividend Aristocrats, which are S&P 500 Index stocks that have raised their dividends for at least 25... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Stop Checking Your Portfolio: How to Invest for the Long Term During a Market Crash
Crashes aren't very frightening if you're mentally and financially prepared. 
Via The Motley Fool
The Best Dividend Aristocrats to Buy With $500 Right Now
You'll even have a little cash left over after buying these great dividend stocks. 
Via The Motley Fool
Abbott's Navitor Aortic Heart Valve Replacement Scores European Approval
Abbott Laboratories’ (NYSE: ABT) Navitor transcatheter aortic valve implantation (TAVI) system has received a CE mark, making it available in Europe to those... 
Via Benzinga
4 Buy-Rated Growth Stocks To Snatch Up In May
Even though growth stocks fell out of favor this year with investors who chose to rotate to cyclical stocks to capitalize on the economic recovery, some stocks are still solid bets considering their... 
Via Talk Markets
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
P/E Ratio Insights for Abbott Laboratories
Looking into the current session, Abbott Laboratories Inc. (NYSE:ABT) is trading at $117.26, after a 0.94% decrease. Over the past month, the stock decreased by 3.49%, but... 
Via Benzinga
Why Vaccines Might Not Spell Downturn For Covid Testing Firms
Investors should hold off permanently rebranding diagnostics stocks as coronavirus stocks, experts say. There's a chance their future could be much bigger. 
Via Investor's Business Daily
Exposures COVID-19
Why Abbott Labs' Sizzling Growth Could Taper Off
There's one key growth driver that's likely to diminish in importance. 
Via The Motley Fool
2 Top Stocks to Buy and Hold for 10 Years
Our constant need for medical products will be a major growth driver for these healthcare giants. 
Via The Motley Fool
3 Top Healthcare Stocks to Buy and Hold for the Next 10 Years
From dividends to growth to overall stability, these stocks will give your portfolio a great mix. 
Via The Motley Fool
Exposures COVID-19
AbbVie- A High Dividend Opportunity
AbbVie (ABBV​​​​​​​) is the seventh-largest pharmaceutical company on the globe in terms of revenue; the company is also a Dividend Aristocrat, having nearly a half-century of dividend growth to its... 
Via Talk Markets
Stock Market Rally Retreats, Bitcoin Dives Amid Biden Capital Gains Tax Plan; Netflix, Snap, United Airlines In Focus
The stock market rally fell modestly with President Biden set to propose a big capital gains tax hike on the wealthy. Bitcoin plunged below $50,000. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
3 Things to Cheer About in Abbott's Earnings Report
And they all will lead to revenue growth. 
Via The Motley Fool
Exposures COVID-19
Does Biogen Stand A Chance Of Topping Bearish First-Quarter Views?
Biogen stock could enjoy some upside Thursday if it outperforms Wall Street's bearish expectations for steep declines in first-quarter sales and earnings. 
Via Investor's Business Daily
Disappointing Subscriber Numbers Hit Netflix Shares, Weighing On Nasdaq Early
Other than earnings, we’ve had almost no numbers to crunch so far this week. That changes starting today. Weekly crude inventories come out later this morning,... 
Via Benzinga
Abbott Laboratories: Debt Insights
Shares of Abbott Laboratories (NYSE:ABT) increased by 5.04% in the past three months. Before we understand the importance of debt, let us look at how much debt Abbott... 
Via Benzinga
Abbott Laboratories Shares Sink on Mixed Q1; New Dividend Declared
COVID-testing products helped beef up revenue and profitability. 
Via The Motley Fool
Abbott Laboratories (ABT) Q1 2021 Earnings Call Transcript
ABT earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street
The healthcare company's COVID-19 tests continued to drive its growth. 
Via The Motley Fool
Exposures COVID-19
Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its... 
Via Benzinga
Abbott Stock Is Trading Lower After Q1 Sales Shy Of Estimates
Abbott Laboratories (NYSE: ABT) has reported Q1 adjusted earnings of $1.32 per share on $10.5 billion in sales for its first quarter. Though EPS was above the... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.